Skip to main content
. 2025 Feb 7;11(6):eadp5539. doi: 10.1126/sciadv.adp5539

Fig. 1. NIR-II/SWIR luminescent nanoparticles for the SARS-CoV-2 pEr-P3-RBD nanovaccine.

Fig. 1.

(A) Schematic of the pEr-P3-RBD (RBD conjugated to ─NH2 groups on the pEr-P3 surface via EDC chemistry). P3 refers to cross-linked three layers of hydrophilic polymers coated on the pEr nanoparticles. (B) TEM image of pEr nanoparticles comprised the NaErF4 core and NaYF4 shell; scale bar, 20 nm. (C) Energy level diagram of the erbium showing the NIR-II down conversion pathway. (D) Absorption (red curve) and emission (blue curve) spectra of pEr nanoparticles in cyclohexane (prior to P3 coating). The dashed vertical line shows the excitation wavelength (975 nm) for pEr nanoparticles. a.u., arbitrary units. (E) DLS spectra of pEr in cyclohexane (gray), hydrophilic pEr-P3 in 1×PBS buffer (blue). The average size for pEr nanoparticles is ~25.5 nm, and that for pEr-P3 nanoparticles is ~55.5 nm.